| Product NDC: | 67457-266 |
| Proprietary Name: | Levetiracetam |
| Non Proprietary Name: | Levetiracetam |
| Active Ingredient(s): | 15 mg/mL & nbsp; Levetiracetam |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 67457-266 |
| Labeler Name: | Mylan Institutional LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA202543 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20111110 |
| Package NDC: | 67457-266-10 |
| Package Description: | 10 BAG in 1 CARTON (67457-266-10) > 100 mL in 1 BAG (67457-266-00) |
| NDC Code | 67457-266-10 |
| Proprietary Name | Levetiracetam |
| Package Description | 10 BAG in 1 CARTON (67457-266-10) > 100 mL in 1 BAG (67457-266-00) |
| Product NDC | 67457-266 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Levetiracetam |
| Dosage Form Name | INJECTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20111110 |
| Marketing Category Name | NDA |
| Labeler Name | Mylan Institutional LLC |
| Substance Name | LEVETIRACETAM |
| Strength Number | 15 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |